LUCIA Understanding Lung Cancer related risk factors and their Impact
- Coordinator
- Technion - Israel Institute of Technology, Israel
- Runs
- 1 January 2023 to 31 December 2026
- Status
- Running
- EU funding
- €13.5m
- Total cost
- €13.5m
- Partners
- 24 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101096473
What the project is doing
In the project's own words, from its summary on CORDIS.
Lung Cancer (LC) is the biggest cancer killer worldwide, with five-year survival following diagnosis varying between 5% to 25%. Though tobacco smoking has long been recognized as the major risk factor for LC, many cases (incl. LC patients that are non-smokers) cannot be explained by this reason. In this sense, LUCIA aims to establish a novel toolbox for discovering and understanding new risk factors that contribute to LC development.
The toolbox encompasses the analysis of three aspects: (i) personal risk factors, which include a person’s exposure to chemical pollutants and behavioural and lifestyle factors; (ii) external risk factors, such as urban, built and transport environments, social aspects and climate; and (iii) biological responses to the personal and external risk factors, including changes in genetics, epigenetics, metabolism and aging.
Key components of the toolbox for analysing personal and external risk factors include retrospective and prospective cohort databases, AI models, wearable devices, novel non-invasive sensors, and multi-omics. Together, these tools will be used to identify the effects of a wide range of environmental, biological, demographic, community and individual-level risk factors associated with the formation of LC. Molecular changes associated with the risk factors identified by this set of tools will then be validated by cell and molecular biology methods and through in vivo analysis.
The impact of the identified personal and external risk factors and the associated biological responses will be then validated in three clinical use cases: general population risk assessment and screening, precision screening of high-risk populations, and digital diagnostics. The resulting evidence within LUCIA will be translated into policymaking recommendations, with the aim to implement them in a screening program for LC.
This action is part of the Cancer Mission cluster of projects on ‘Understanding'.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Technion - Israel Institute of Technology | Haifa | Israel | Coordinator |
| Centre Hospitalier Universitaire De Liege | Liege | Belgium | Participant |
| European Hospital and Healthcare Federation | Bruxelles / Brussel | Belgium | Participant |
| Timelex | Bruxelles / Brussel | Belgium | Participant |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Participant |
| Ruprecht-Karls-Universitaet Heidelberg | Heidelberg | Germany | Participant |
| Asociacion Instituto De Investigacion Sanitaria Biobizkaia | Barakaldo Bizkaia | Spain | Participant |
| Bilbomatica SA | Bilbao | Spain | Participant |
| Consorcio Para La Explotacion Del Centro Nacional De Analisis Genomico | Barcelona | Spain | Participant |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Participant |
| Fundacio Institut De Recerca Biomedica (irb Barcelona) | Barcelona | Spain | Participant |
| Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones Vicomtech | Donostia San Sebastian | Spain | Participant |
| Fundacion Para La Gestion De La Investigacion En Salud De Sevilla | Sevilla | Spain | Third party |
| Servicio Andaluz De Salud | Sevilla | Spain | Participant |
| Servicio Vasco de Salud Osakidetza | Vitoria-Gasteiz | Spain | Third party |
| Universidad Politecnica De Madrid | Madrid | Spain | Participant |
| Nanose Medical Ltd | Netanya | Israel | Participant |
| Pronat Indutries Ltd | Emek Hefer | Israel | Participant |
| Technion Research and Development Foundation Ltd | Haifa | Israel | Third party |
| DEXAI - Etica Artificiale | Roma | Italy | Participant |
| Latvijas Universitate | Riga | Latvia | Participant |
| Yaghma B.v. | Delft | Netherlands | Participant |
| Emoda Yazilim Ve Danismanlik Sanayiticaret Limited Sirketi | İzmir | Türkiye | Participant |
| University of Ulster | Coleraine | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI